AdaptHealth (AHCO) Net Cash Flow (QoQ) (2018 - 2026)
AdaptHealth (AHCO) Net Cash Flow (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.10 Bn | 176.81 Bn | 6.27 Bn |
| 2 | Stryker | 128.79 Bn | 125.91 Bn | 3.81 Bn |
| 3 | Medtronic | 108.97 Bn | 99.75 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.57 Bn | 67.12 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.40 Bn | 26.11 Bn | 1.98 Bn |
| 7 | Dexcom | 28.32 Bn | 27.20 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.94 Bn | 26.36 Bn | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.33 Bn | 2.07 Bn |
| 10 | AdaptHealth | 1.48 Bn | 1.43 Bn | 111.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -325.66% |
| Dec 31, 2025 | 119.83% |
| Sep 30, 2025 | -21.72% |
| Jun 30, 2025 | 126.70% |
| Mar 31, 2025 | -686.36% |
| Dec 31, 2024 | -68.48% |
| Sep 30, 2024 | 411.77% |
| Jun 30, 2024 | -499.92% |
| Mar 31, 2024 | -88.40% |
| Dec 31, 2023 | 90.51% |
| Sep 30, 2023 | 119.58% |
| Jun 30, 2023 | -202.08% |
| Mar 31, 2023 | 185.52% |
| Dec 31, 2022 | -698.74% |
| Sep 30, 2022 | -1,203.88% |
| Jun 30, 2022 | 97.95% |
| Mar 31, 2022 | 83.85% |
| Dec 31, 2021 | -218.02% |
| Sep 30, 2021 | 244.10% |
| Jun 30, 2021 | 43.13% |